Timothy Dixon
Urology · Ashland, KYNPI 1225026438
Payments from drug & device makers
Across 188 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$777
- AbbVie$318
- Antares Pharma, Inc.$242
- Pfizer$224
- Johnson & Johnson$217
- Bayer$195
- plus $865 from 15 others
What the payments were for
- Food & beverage$2,73596%
- Education$813%
- Other$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 63 | $777 |
| AbbVie(2 entities) | 22 | $318 |
| Antares Pharma, Inc. | 13 | $242 |
| Pfizer | 15 | $224 |
| Johnson & Johnson | 12 | $217 |
| Bayer | 15 | $195 |
| Endo Pharmaceuticals Inc. | 12 | $166 |
| Myriad Genetic Laboratories, Inc. | 6 | $92 |
| Medtronic | 3 | $90 |
| Axonics, Inc. | 6 | $88 |
| Urovant Sciences Inc | 5 | $78 |
| Procept Biorobotics Corporation | 3 | $69 |
| Myovant Sciences Inc. | 4 | $62 |
| Boston Scientific | 1 | $59 |
| 180 Medical, Inc. | 2 | $44 |
| Novo Nordisk | 1 | $24 |
| Olympus America Inc. | 1 | $23 |
| Neotract Inc. | 1 | $21 |
| Conmed Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $15 |
How this compares
$2,839 in reported general payments places this provider in the 50th percentile of 139 urology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 30 | $18,731 |
| Tamsulosin Hcl | 53 | $647 |
| Finasteride | 33 | $418 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $317 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $777 | $18,73130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 139 urology providers in Kentucky.
Other urology in Ashland
- Jeremy BonzoAshland$7K
- William BoykinAshland$5K
- Brian DefadeAshland$4K
- Justin DixonAshland$4K
- Daniel HettelAshland$3K
- Patrick HensleyLexington$153K
- Thomas SlabaughLexington$102K
- Uzoma AneleLouisville$60K
- Lee EvansHopkinsville$56K
- Brooke EdwardsCrestview Hills$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.